Growth Metrics

Novartis Ag (NVS) Current Taxes (2016 - 2025)

Novartis Ag's Current Taxes history spans 15 years, with the latest figure at $2.0 billion for Q4 2025.

  • On a quarterly basis, Current Taxes rose 23.14% to $2.0 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $2.0 billion, a 23.14% increase, with the full-year FY2025 number at $2.0 billion, up 23.14% from a year prior.
  • Current Taxes hit $2.0 billion in Q4 2025 for Novartis Ag, down from $2.8 billion in the prior quarter.
  • Over the last five years, Current Taxes for NVS hit a ceiling of $2.8 billion in Q2 2025 and a floor of -$1.0 billion in Q2 2021.
  • Historically, Current Taxes has averaged $1.6 billion across 5 years, with a median of $1.9 billion in 2024.
  • Biggest five-year swings in Current Taxes: soared 344.01% in 2022 and later decreased 27.61% in 2024.
  • Tracing NVS's Current Taxes over 5 years: stood at $2.4 billion in 2021, then increased by 4.89% to $2.5 billion in 2022, then dropped by 25.27% to $1.9 billion in 2023, then decreased by 15.53% to $1.6 billion in 2024, then grew by 23.14% to $2.0 billion in 2025.
  • Business Quant data shows Current Taxes for NVS at $2.0 billion in Q4 2025, $2.8 billion in Q2 2025, and $1.6 billion in Q4 2024.